Month: November 2022

OMAHA, Neb., Nov. 30, 2022 (GLOBE NEWSWIRE) — Green Plains announced today that Todd Becker, President and CEO, will participate in a fireside chat at the virtual BMO 2022 Growth & ESG Conference Tuesday, December 6 at 9 a.m. Eastern time (8 a.m. Central time). Additionally, the company will be participating in meetings with institutional investors during the conference. Following the conference, a replay of the fireside chat will be available on the Investors page of Green Plains’ website at https://investor.gpreinc.com/events-presentations. About Green Plains Inc.Green Plains Inc. (NASDAQ:GPRE) is a leading biorefining company focused on the development and utilization of fermentation, agricultural and biological technologies in the processing of annually renewable crops into sustainable value-added ingredients. This includes...

Increase of share capital of Play and results of share offering A shareholders‘ meeting of Fly Play hf. held on 30 November 2022 approved the below stated proposals, which authorise the board of directors decided to increase the Company‘s share capital by up to ISK 228.670.505 in nominal value with the issuance of new shares, resulting in gross proceeds of approx. ISK 3,3 billion. The goal of the share capital increase is to strengthen the company for the coming growth and to ensure its strong liquidity position. Play‘s 20 largest shareholders participated in the increase. To ensure shareholder equality all shareholders were afforded the opportunity to subscribe for new shares on the same terms. As the current market value of shares is lower than the subscription price there was very limited participation. As a result of the above the...

AUGA group, AB and its subsidiaries (hereinafter – the Group) improved their operating results in the first nine months of the year. The sales revenue during the first nine months of 2022 was EUR 57.71 million, an increase of 5% compared to EUR 54.90 million in the same period last year. In the first nine months of 2022, the Group’s gross profit was EUR 13.14 million, representing an increase of 673% compared to the previous year (EUR 1.70 million). The Group’s net loss from EUR 10.43 million fixed in the three quarters of 2021, decreased to EUR 0.62 million in three quarters of 2022. The Group‘s EBITDA for the first nine months of 2022 increased by 208% to EUR 16.78 million compared to EUR 5.45 million in the same period of 2021. “Better financial results were determined by the good harvest of 2022 and increased production...

KANSAS CITY, Kan., Nov. 30, 2022 (GLOBE NEWSWIRE) — Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and advance a pipeline of next-generation pharmaceutical products, today announced that Chairman and CEO Shane J. Schaffer will participate in a live Benzinga All Access event on Friday December 2, 2022, at 10 a.m. CST. The discussion will address the current unmet needs in Attention Deficit/Hyperactivity Disorder (ADHD), as well as the expansion of Cingulate’s PTR platform into the anxiety therapeutic area. Dr. Schaffer will also provide a company overview. The event may be viewed live on Benzinga’s YouTube channel, Benzinga All Access, and will also be available for viewing on Cingulate’s website at cingulate.com/investors. About...

Solutions 30 confirms the Group submitted in early November a first offer to acquire part of Scopelec’s assets and is currently working on a new and improved proposal. Solutions 30 intends to propose a solid and sustainable solution. Solutions 30 Group is already well established in many regions of France through a dense network with many contracts in both the telecom segment and activities driving growth, such as renewable energies and charging stations for electric vehicles. As such, the acquisition of part of Scopelec’s assets would consolidate the Group’ s development plan and would offer new opportunities for Scopelec’s employees. Solutions 30’s offer is designed to be combined with those of other bidders. The proposed improved offer will be subject to the approval of the Lyon Commercial Court, which will...

Alvotech S.A. (“Alvotech”) has submitted its application to Nasdaq Iceland for admission of its shares for trading on the Nasdaq Iceland Main Market under the ticker symbol “ALVO”. The application awaits approval from Nasdaq Iceland. Alvotech’s shares are currently listed on the Nasdaq Stock Market in the U.S. and on the Nasdaq First North Growth Market under the ticker symbol “ALVO”. Alvotech’s shares were admitted to trading in the U.S. on June 16, 2022 and in Iceland on June 23, 2022. On 12 August 2022, Alvotech announced that the Board of Directors had approved a plan to move its share listing to the Nasdaq Main Market in Iceland. Alvotech Investor Relations and Global CommunicationBenedikt Stefansson alvotech.ir[at]alvotech.com

Led by Supplier of the Year, ADI VAN BUREN TOWNSHIP, Mich., Nov. 30, 2022 (GLOBE NEWSWIRE) — Visteon Corporation (Nasdaq: VC), recognized its outstanding supplier partners during the 2022 Strategic Supplier Award ceremony in Ann Arbor. A total of nine different suppliers across the automotive and technology spaces were recognized by Visteon, highlighted by the supplier of the year award-winner, Analog Devices (ADI). Attendance at the ceremony included executive leadership from over 50 suppliers and multiple members of the Visteon team, including President and CEO Sachin Lawande, who presented the awards. Despite unforeseen challenges throughout the dynamic automotive industry landscape, Visteon proudly recognizes its suppliers and is thankful for their ongoing partnership to achieve world-class results. “We are grateful to this...

WOBURN, Mass., Nov. 30, 2022 (GLOBE NEWSWIRE) — Biofrontera Inc. (Nasdaq: BFRI), a biopharmaceutical company specializing in the commercialization of dermatological products, announced today that the Company will be participating in Benchmark’s 11th Annual Discovery One-on-One Investor Conference being held on December 1, 2022 in New York, NY. Erica Monaco, Chief Executive Officer, and Hermann Lübbert, Executive Chairman of Biofrontera Inc. will be meeting with registered investors in one-on-one meetings and small-group sessions. About Biofrontera Inc. Biofrontera Inc. is a U.S.-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on PDT and topical antibiotics. The Company’s licensed products are used for the treatment of actinic keratoses,...